Classification of atypical EGFR mutations in non-small-cell lung cancer von Rosell, R., Cardona, A.F., Arrieta, O., González-Cao, M.

Volltext

Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions von Mayo-de-las-Casas, C., Jordana-Ariza, N., Garzón-Ibañez, M., Balada-Bel, A., Bertrán-Alamillo, J., Viteri-Ramírez, S., Reguart, N., Muñoz-Quintana, M.A., Lianes-Barragan, P., Camps, C., Jantús, E., Remon-Massip, J., Calabuig, S., Aguiar, D., Gil, M.L., Viñolas, N., Santos-Rodríguez, A.K., Majem, M., García-Peláez, B., Villatoro, S., Pérez-Rosado, A., Monasterio, J.C., Ovalle, E., Catalán, M.J., Campos, R., Morales-Espinosa, D., Martínez-Bueno, A., González-Cao, M., González, X., Moya-Horno, I., Sosa, A.E., Karachaliou, N., Rosell, R., Molina-Vila, M.A.

Volltext

Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV) von Botella-Estrada, R, Boada-García, A, Carrera-Álvarez, C, Fernández-Figueras, M, González-Cao, M, Moreno-Ramírez, D, Nagore, E, Ríos-Buceta, L, Rodríguez-Peralto, J L, Samaniego-González, E, Tejera-Vaquerizo, A, Vílchez-Márquez, F, Descalzo-Gallego, M A, García-Doval, I

Volltext

Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case–control study von Massi, D, Puig, S, Franchi, A, Malvehy, J, Vidal-Sicart, S, González-Cao, M, Baroni, G, Ketabchi, S, Palou, J, Santucci, M

Volltext

Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types von Paré, L., Pascual, T., Seguí, E., Teixidó, C., Gonzalez-Cao, M., Galván, P., Rodríguez, A., González, B., Cuatrecasas, M., Pineda, E., Torné, A., Crespo, G., Martin-Algarra, S., Pérez-Ruiz, E., Reig, Ò, Viladot, M., Font, C., Adamo, B., Vidal, M., Gaba, L., Muñoz, M., Victoria, I., Ruiz, G., Viñolas, N., Mellado, B., Maurel, J., Garcia-Corbacho, J., Molina-Vila, M Á, Juan, M., Llovet, J.M., Reguart, N., Arance, A., Prat, A.

Volltext

Preliminary Results of the Combination of Bevacizumab and Weekly Paclitaxel in Advanced Melanoma von González-Cao, M., Viteri, S., Díaz-Lagares, A., González, A., Redondo, P., Nieto, Y., Espinós, J., Chopitea, A., Ponz, M., Martín-Algarra, S.

Volltext

Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program von González-Cao, M., Arance, A., Piulats, J. M., Marquez-Rodas, I., Manzano, J. L., Berrocal, A., Crespo, G., Rodriguez, D., Perez-Ruiz, E., Berciano, M., Soria, A., Castano, A. G., Espinosa, E., Montagut, C., Alonso, L., Puertolas, T., Aguado, C., Royo, M. A., Blanco, R., Rodríguez, J. F., Muñoz, E., Mut, P., Barron, F., Martin-Algarra, S.

Volltext

Cancer immunotherapy of patients with HIV infection von Gonzalez-Cao, M., Martinez-Picado, J., Karachaliou, N., Rosell, R., Meyerhans, A.

Volltext

SEOM clinical guideline for the management of cutaneous melanoma (2020) von Majem, M., Manzano, J. L., Marquez-Rodas, I., Mujika, K., Muñoz-Couselo, E., Pérez-Ruiz, E., de la Cruz-Merino, L., Espinosa, E., Gonzalez-Cao, M., Berrocal, A.

Volltext

Molecular analysis of NRAS, BRAF, C-KIT, ROS1, ALK and RET alterations in serial biopsies in sinonasal mucosal melanoma von Anguera Palacios, G., del Carpio, L.P., Molina, M.-A., Aguado, C., Gras-Cabrerizo, J.R., Leon, X., Gonzalez-Cao, M., Karachaliou, N., Mozos, A., Gonzalez, A., Barnadas, A., Rosell, R., Majem, M.

Volltext

254 Molecular analysis in breast cancer: correlation with Immunohistochemical classification and pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) von Baulies, S, Gonzalez-Cao, M, Karachaliou, N, Capitan, A. Rodriguez, Molina-Vila, M.A, Cusido, M.T, Teixido, C, Viteri, S, Fabregas, R, Gonzalez, X, Rosell, R

Volltext

354 PCR-based assay for BRAFV600 mutation analysis in ctDNA: clinical results from plasma and serum samples von Gonzalez-Cao, M, de las Casas, C. Mayo, Molina-Vila, M.A, de Mattos-Arruda, L, Manzano, J.L, Munoz, E, Cortes, J, Berros, J.P, Sanmamed, M, Gonzalez, A, Alvarez, C, Karachaliou, N, Jordana-Ariza, N, Algarra, S. Martin, Rosell, R

Volltext

514 Hypoxia inducible factor (HIF)-1a expression levels and p53 mutations are prognostic factors for survival in breast cancer patients treated with neoadjuvant chemotherapy von Molina-Vila, M, Baulies, S, Gonzalez-Cao, M, Karachaliou, N, Capitan, A. Rodriguez, Viteri, S, Cusido, M, Fabregas, R, Teixido, C, Rosell, R

Volltext

Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab von González Cao, M, Viteri, S, Garrán, C, Nieto, Y, Aristu, J, Ponz, M, Martín Algarra, S

Volltext

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis von Duruisseaux, Michäel, Martínez-Cardús, Anna, Calleja-Cervantes, Maria E, Moran, Sebastian, Castro de Moura, Manuel, Davalos, Veronica, Piñeyro, David, Sanchez-Cespedes, Montse, Girard, Nicolas, Brevet, Marie, Giroux-Leprieur, Etienne, Dumenil, Coraline, Pradotto, Monica, Bironzo, Paolo, Capelletto, Enrica, Novello, Silvia, Cortot, Alexis, Copin, Marie-Christine, Karachaliou, Niki, Gonzalez-Cao, Maria, Peralta, Sergio, Montuenga, Luis M, Gil-Bazo, Ignacio, Baraibar, Iosune, Lozano, Maria D, Varela, Mar, Ruffinelli, Jose C, Palmero, Ramon, Nadal, Ernest, Moran, Teresa, Perez, Lidia, Ramos, Immaculada, Xiao, Qingyang, Fernandez, Agustin F, Fraga, Mario F, Gut, Marta, Gut, Ivo, Teixidó, Cristina, Vilariño, Noelia, Prat, Aleix, Reguart, Noemi, Benito, Amparo, Garrido, Pilar, Barragan, Isabel, Emile, Jean-François, Rosell, Rafael, Brambilla, Elisabeth, Esteller, Manel

Volltext

Melanoma Inhibiting Activity Protein (MIA), Beta-2 Microglobulin and Lactate Dehydrogenase (LDH) in Metastatic Melanoma von GONZALEZ CAO, M, AUGE, J. M, PUIG, S, MOLINA, R, MARTI, R, CARRERA, C, CASTEL, T, VILELLA, R, CONILL, C, SANCHEZ, M, MALVEHY, J

Volltext

613MO A phase I clinical trial evaluating exarafenib, a selective pan-RAF inhibitor in combination with binimetinib in NRAS-mutant (NRASMut) melanoma (Mel) & BRAF-altered solid tum... von Cassier, P., Mehnert, J.M., Kim, R., Chmielowski, B., Millward, M., Perez, C.A., Gonzalez Cao, M., Gambardella, V., Mckean, M., Brose, M.S., Xing, Y., Long, G.V., Kelly, A., Lee, G., Severson, P., Williams, R., Gaudy Marqueste, C.

Volltext

79TiP Progress of a phase I trial (TOTEM) of repotrectinib in combination with osimertinib in advanced, metastatic EGFR mutant NSCLC von Aguilar, A., Cobo, M., Azkarate, A., Calles, A., Gonzalez-Cao, M., Cantero, A., Terrasa, J., Álvarez, R., Molina, M.Á., Rosell, R.

Volltext

2325P Selinexor (XPO1 inhibitor) in combination with tepotinib (MET inhibitor) potentially inhibits SHOC2 and KRAS G12C in KRAS G12C mutant non-small cell lung cancer von Rosell, R., Jain, A., Codony-Servat, J., Shivamallu, C., Kollur, S.P., Prasad, A., Vishwanath, P., Jantus Lewintre, E., Ito, M., Cardona Zorrilla, A.F., Arrieta Rodriguez, O.G., Pedraz-Valdunciel, C., González Nieto, J., Aguilar, A., Molina-Vila, M.A., Gonzalez Cao, M.

Volltext

S-100β and MIA in advanced melanoma in relation to prognostic factors von AUGE, J. M, MOLINA, R, FILELLA, X, BOSCH, E, GONZALEZ CAO, M, PUIG, S, MALVEHY, J, CASTEL, T, BALLESTA, A. M

Volltext